Balaxi Pharmaceuticals Ltd. submitted RTA reports on physical share transfers as per SEBI circular.
Reports from Aarthi Consultants Pvt. Ltd. for February and March 2026 showed zero transfer requests.
The company disclosed nil activity across all metrics including requests received, processed, approved, and rejected.
This is a procedural compliance filing with no material financial or operational impact.